Šime Brkić

589 total citations
12 papers, 442 citations indexed

About

Šime Brkić is a scholar working on Genetics, Hematology and Molecular Biology. According to data from OpenAlex, Šime Brkić has authored 12 papers receiving a total of 442 indexed citations (citations by other indexed papers that have themselves been cited), including 7 papers in Genetics, 6 papers in Hematology and 5 papers in Molecular Biology. Recurrent topics in Šime Brkić's work include Chronic Myeloid Leukemia Treatments (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers) and Acute Myeloid Leukemia Research (3 papers). Šime Brkić is often cited by papers focused on Chronic Myeloid Leukemia Treatments (5 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (5 papers) and Acute Myeloid Leukemia Research (3 papers). Šime Brkić collaborates with scholars based in Switzerland, United States and United Kingdom. Šime Brkić's co-authors include Sara C. Meyer, Andrea Banfi, Roberto Giannì-Barrera, Maximilian G. Burger, Jeffrey A. Hubbell, Dirk J. Schaefer, Hans M. Larsson, Mikaël M. Martino, Priscilla S. Briquez and Thomas Wolff and has published in prestigious journals such as Journal of Clinical Investigation, Blood and Clinical Cancer Research.

In The Last Decade

Šime Brkić

11 papers receiving 440 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Šime Brkić Switzerland	8	222	161	94	81	74	12	442
Thibault Bouderlique Sweden	15	248 1.1×	87 0.5×	171 1.8×	73 0.9×	81 1.1×	26	738
LouAnn Gross United States	10	161 0.7×	74 0.5×	46 0.5×	80 1.0×	45 0.6×	11	886
Marijke W. Maijenburg Netherlands	9	197 0.9×	193 1.2×	32 0.3×	126 1.6×	84 1.1×	12	551
Christian Niehage Germany	10	249 1.1×	114 0.7×	82 0.9×	25 0.3×	152 2.1×	11	569
Bo‐Ra Son South Korea	6	211 1.0×	381 2.4×	52 0.6×	41 0.5×	174 2.4×	9	633
Elena Groppa Switzerland	9	290 1.3×	108 0.7×	114 1.2×	13 0.2×	132 1.8×	12	568
Qiongfang Cao China	6	136 0.6×	313 1.9×	97 1.0×	32 0.4×	180 2.4×	16	485
Demetrios C. Nikas United States	9	290 1.3×	154 1.0×	68 0.7×	16 0.2×	60 0.8×	16	817
Stefanie Liedtke Germany	7	235 1.1×	362 2.2×	50 0.5×	48 0.6×	200 2.7×	12	552

Countries citing papers authored by Šime Brkić

Since Specialization

Citations

This map shows the geographic impact of Šime Brkić's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Šime Brkić with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Šime Brkić more than expected).

Fields of papers citing papers by Šime Brkić

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Šime Brkić. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Šime Brkić. The network helps show where Šime Brkić may publish in the future.

Co-authorship network of co-authors of Šime Brkić

This figure shows the co-authorship network connecting the top 25 collaborators of Šime Brkić. A scholar is included among the top collaborators of Šime Brkić based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Šime Brkić. Šime Brkić is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Brkić, Šime, et al.. (2025). TLD: An optimized liposomal doxorubicin formulation with small vesicle size for improved anti-tumor efficacy. European Journal of Pharmaceutical Sciences. 213. 107246–107246.

Dunbar, Andrew, Simona Stivala, Šime Brkić, et al.. (2023). Development of Resistance to Type II JAK2 Inhibitors in MPN Depends on AXL Kinase and Is Targetable. Clinical Cancer Research. 30(3). 586–599. 1 indexed citations

Parmigiani, Elena, Robert Ivánek, Chiara Rolando, et al.. (2022). Interferon-γ resistance and immune evasion in glioma develop via Notch-regulated co-evolution of malignant and immune cells. Developmental Cell. 57(15). 1847–1865.e9. 26 indexed citations

Brkić, Šime, Simona Stivala, Katarzyna Buczak, et al.. (2022). Escape from Type II JAK2 Inhibition in MPN Depends on AXL/MAPK Activation and Is Targetable. Blood. 140(Supplement 1). 3850–3851. 1 indexed citations

Halter, Jörg, Nathan Cantoni, Friedel Wenzel, et al.. (2022). Co-Occurring CSF3R W791* Germline and Somatic T618I Driver Mutations Induce Early CNL and Clonal Progression to Mixed Phenotype Acute Leukemia. Current Oncology. 29(2). 805–815. 3 indexed citations

Brkić, Šime, Simona Stivala, Jakob Passweg, et al.. (2021). Dual targeting of JAK2 and ERK interferes with the myeloproliferative neoplasm clone and enhances therapeutic efficacy. Leukemia. 35(10). 2875–2884. 21 indexed citations

Brkić, Šime & Sara C. Meyer. (2020). Challenges and Perspectives for Therapeutic Targeting of Myeloproliferative Neoplasms. HemaSphere. 5(1). e516–e516. 26 indexed citations

Stivala, Simona, Šime Brkić, Anne Baerenwaldt, et al.. (2019). Targeting compensatory MEK/ERK activation increases JAK inhibitor efficacy in myeloproliferative neoplasms. Journal of Clinical Investigation. 129(4). 1596–1611. 72 indexed citations

Groppa, Elena, Šime Brkić, Petra Korpisalo, et al.. (2018). EphrinB2/EphB4 signaling regulates non‐sprouting angiogenesis by VEGF. EMBO Reports. 19(5). 65 indexed citations

10.

Matić, Igor, Maja Antunović, Šime Brkić, et al.. (2016). Expression of OCT-4 and SOX-2 in Bone Marrow-Derived Human Mesenchymal Stem Cells during Osteogenic Differentiation. Open Access Macedonian Journal of Medical Sciences. 4(1). 9–16. 43 indexed citations

11.

Martino, Mikaël M., Šime Brkić, Maximilian G. Burger, et al.. (2015). Extracellular Matrix and Growth Factor Engineering for Controlled Angiogenesis in Regenerative Medicine. Frontiers in Bioengineering and Biotechnology. 3. 45–45. 152 indexed citations

12.

Groppa, Elena, Šime Brkić, Veronica Sacchi, et al.. (2015). VEGF dose regulates vascular stabilization through Semaphorin3A and the Neuropilin‐1 ⁺ monocyte/ TGF ‐β1 paracrine axis. EMBO Molecular Medicine. 7(10). 1366–1384. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact